Investors Research Corp’s Biogen BIIB Stock Holding History

Investors Research Corp’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$352K	Sell	1,558 -83	-5%	-$17.6K	0.06%	208
2026 Q2	$355K	Sell	1,641 -209	-11%	-$40K	0.06%	203
2026 Q1	$339K	Hold	1,850	–	–	0.06%	212
2025 Q4	$326K	Hold	1,850	–	–	0.06%	238
2025 Q3	$259K	Hold	1,850	–	–	0.05%	271
2025 Q2	$232K	Buy	+1,850	New	+$231K	0.05%	284
2020 Q4	–	Sell	-10	Closed	-$3K	–	1076
2020 Q3	$3K	Hold	10	–	–	﹤0.01%	961
2020 Q2	$3K	Hold	10	–	–	﹤0.01%	963
2020 Q1	$3K	Hold	10	–	–	﹤0.01%	966
2019 Q4	$3K	Hold	10	–	–	﹤0.01%	989
2019 Q3	$2K	Hold	10	–	–	﹤0.01%	1017
2019 Q2	$2K	Hold	10	–	–	﹤0.01%	956
2019 Q1	$2K	Buy	+10	New	+$3.15K	﹤0.01%	933

Other funds holding BIIB

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SCI

Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return

BCM

Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Investors Research Corp's BIIB Position: Q3 2026 in Review

Investors Research Corp reduced its Biogen (BIIB) stake by 5.1% in Q3 2026, selling an estimated $17.6K and leaving 1,558 shares worth $352K. The position accounts for 0.06% of the portfolio, ranked #208.

Investors Research Corp first reported a position in BIIB in Q1 2019 and has held it in 13 quarters since. The position peaked at $355K in Q2 2026. 41 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Investors Research Corp held 1,558 shares of Biogen worth $352K as of Q3 2026.
Investors Research Corp sold 83 Biogen shares in Q3 2026, an estimated $17.6K.
Biogen made up 0.06% of Investors Research Corp's portfolio in Q3 2026, its #208 holding.
Investors Research Corp first reported a position in Biogen in Q1 2019 and has held it in 13 quarters since.
Investors Research Corp's Biogen position peaked at $355K in Q2 2026.
41 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.